Richard Christopher's Net Worth

$2.72 Million

Estimate Recalculated Apr 3, 2024 05:35PM EST

Who is Richard Christopher?

Richard Christopher has an estimated net worth of $2.72 Million. This is based on reported shares across multiple companies, which include ICAD INC, INVIVO THERAPEUTICS HOLDINGS CORP., DUSA PHARMACEUTICALS INC, and LUCID INC.

SEC CIK

Richard Christopher's CIK is 0001271244

Past Insider Trading and Trends

2010 was Richard Christopher's most active year for acquiring shares with 4 total transactions. Richard Christopher's most active month to acquire stocks was the month of February. 2011 was Richard Christopher's most active year for disposing of shares, totalling 18 transactions. Richard Christopher's most active month to dispose stocks was the month of April. 2018 saw Richard Christopher paying a total of $199,665.64 for 88,333 shares, this is the most they've acquired in one year. In 2012 Richard Christopher cashed out on 523,052 shares for a total of $2,278,516.10, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ICAD INC (ICAD) Snapshot price: $1.41

Executive VP and CFO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Dec 21
Form 4
-4.00%
-4.91K
$4.08
-$20,028.72
117.85K
Dec 5
Form 4
+25.71%
51.6K
$3.08
$158,921.84
252.26K
Mar 30
Form 4
+54.15%
25K
—
—
71.17K
Mar 22
Form 4
-10.49%
-5.41K
$3.52
-$19,039.68
46.16K
Dec 5
Form 4
+3.15%
1.57K
—
—
51.57K
May 4
Form 4
∞
50K
—
—
50K
Dec 5
Form 3
—
0
—
—
0
No matching records found

INVIVO THERAPEUTICS HOLDINGS CORP. (NVIV) Snapshot price: $0.6001

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Nov 17
Form 4
—
0
—
—
0
Mar 18
Form 4
+229.55%
3.64K
—
—
5.22K
Mar 10
Form 4
∞
47.5K
—
—
47.5K
Sep 25
Form 4
—
0
—
—
0
Jan 14
Form 3
—
0
—
—
0
No matching records found

DUSA PHARMACEUTICALS INC No price found

VP Finance & CFO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-276.01K
$8.00
-$2,208,096.00
0
Dec 20
Form 4
+2.79%
7.5K
$1.60
$12,000.00
276.01K
Nov 13
Form 4
-0.38%
-1.03K
$6.13
-$6,313.90
268.51K
May 9
Form 4
-1.09%
-2.98K
$5.86
-$17,462.80
269.54K
Mar 13
Form 4
+43.02%
124.85K
$6.05
-$31,163.55
415.04K
Mar 7 - Mar 8
Form 4
-2.20%
-3.33K
$4.65
-$15,479.85
147.67K
Mar 5
Form 4
—
0
$3.74
-$187,593.15
151K
May 12
Form 4
-0.68%
-1.03K
$5.80
-$5,985.60
151K
May 9
Form 4
-1.93%
-2.98K
$4.15
-$12,387.75
152.03K
Mar 13
Form 4
+33.63%
61.67K
$3.95
-$13,169.30
245.04K
Mar 4 - Mar 7
Form 4
-1.09%
-1.03K
$2.01
-$2,074.32
93.35K
May 9
Form 4
-3.29%
-3.21K
$1.78
-$5,722.70
94.39K
Mar 12
Form 4/A
+75.54%
42K
—
—
97.6K
Mar 5
Form 4
+75.54%
42K
—
—
97.6K
Mar 5
Form 4
+208.89%
37.6K
—
—
55.6K
Mar 13
Form 4
+6.39%
5K
$2.00
$10,000.00
83.25K
Aug 18
Form 4
∞
13K
—
—
13K
May 9
Form 4
—
0
—
—
0
Mar 20
Form 4
—
0
—
—
0
Mar 27
Form 4
—
0
—
—
0
Mar 17
Form 4
—
0
—
—
0
Mar 18
Form 3
—
0
—
—
0
No matching records found

LUCID INC No price found

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found